RAD101 targets fatty acid synthase, overexpressed in many solid tumors, to improve brain metastases imaging. Fast track designation by the FDA accelerates development for treatments addressing unmet ...
GE HealthCare announces first patient dosed in Phase 2/3 LUMINA trial for manganese-based MRI contrast agent under FDA Fast Track designation ...
BR55 (perfluorobutane/nitrogen lipopeptide-coated microbubbles) injection, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the detection of active bowel ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results